Luis Villafaña-Diaz

5PUBLICATIONS
7CO-AUTHORS
Marketing research methodologyRegenerative medicine (incl. stem cells)Gene and molecular therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 10, 2024
Patenting trends by Mexican pharmaceutical companies.

Luis Villafaña-Diaz, Juan C Perez-Garcia, Diana Barron-Villaverde

|Nov 20, 2023
Drug repurposing of rimantadine for treatment of cancer.

Nemesio Villa-Ruano, Vianey Marin-Cevada, Gabriela Sanchez-Esgua

|Oct 06, 2023
Drug repurposing of mito-atovaquone for cancer treatment.

Nemesio Villa-Ruano, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz

|Nov 18, 2022
Approaches for development of LAG-3 inhibitors and the promise they hold as anticancer agents.

Martin Perez-Santos, Maricruz Anaya-Ruiz, Luis Villafaña-Diaz

|Apr 08, 2021
Treatment of solid tumors using bispecific anti-PDL-1/ICOS antibody.

Martin Perez-Santos, Maricruz Anaya-Ruiz, Gabriela Sanchez-Esgua

Pageof 1

Frequent Collaborators

5 joint publications

Martin Perez-Santos

3 joint publications

Maricruz Anaya-Ruiz

3 joint publications

Gabriela Sanchez-Esgua

3 joint publications

Diana Barron-Villaverde